Page last updated: 2024-08-24

4-nitrophenylalanine and Bone Loss, Osteoclastic

4-nitrophenylalanine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, F; Li, H; Lu, Z; Sha, X; Tao, H; Wu, T; Yang, W; Zhai, Q; Zhang, B1

Other Studies

1 other study(ies) available for 4-nitrophenylalanine and Bone Loss, Osteoclastic

ArticleYear
A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice.
    Biochemical and biophysical research communications, 2018, 05-15, Volume: 499, Issue:3

    Topics: Amino Acid Sequence; Animals; Bone Resorption; Cell Differentiation; Female; Immunization; Immunoglobulin G; Mice, Inbred C57BL; Osteoclasts; Ovariectomy; Phenylalanine; RANK Ligand; Vaccines

2018